Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Mar 30, 2023 · 10-K · 89 days after period end · 0001493152-23-009799
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | — |
| Net Income | $893.46K | -$177.74K | -$453.71K | -$531.15K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end
